Denis Lucquin - Profile and Investment Details

Investor Profile

Denis Lucquin is a Venture Capital, Private Equity Firm, Investor based in Paris, Île-de-France, France with a diverse investment portfolio that includes companies such as Noema Pharma, ENYO Pharma, Abivax, Aledia, Genespire, MedDay, CorVent Medical, HighLife, Redx Pharma, Breath Therapeutics, EnginZyme, Asceneuron, Crescendo Biologics, Enthera, AblaCare, DNA Script, Comet Biorefining, Green Biologics, Hookipa Pharma, Inventiva Pharma, CinCor Pharma, GenSight Biologics, SafeHeal, Micropep Technologies, InCarda Therapeutics, AFYX Therapeutics, Sitryx Therapeutics, Pyrowave, Nitrome Biosciences, Delinia, EnobraQ, Pi-Cardia, Avantium, Twenga, NodThera, HotSpot Therapeutics, Microphyt, Catamaran Bio, Inotrem, Mainstay Medical, Biotalys, Corwave, Credit Lyonnais, Rgenix, Synthace, Zyl, BiosyntiaCheckmate Pharmaceuticals, AFYREN, MISSION Therapeutics, Myricx Pharma, CelluComp, Corvidia, ReCor Medical, myTomorrows, Protera, Comet Therapeutics, MD Start, DMC Biotechnologies, Castle Biosciences, Avantium Technologies, Twentyeight-Seven Therapeutics, RefleXion Medical, TISSIUM, BioAmber, Odoo, Shockwave Medical, PinCell s.r.l., Epsilen Bio, LimFlow SA, Erydel, IOmx Therapeutics, ObsEva, Pixium Vision, POLYNEURON, . Over time, Denis Lucquin has demonstrated experience in supporting a range of businesses across various sectors.

While it is not publicly confirmed whether Denis Lucquin is currently seeking new investment opportunities, their past investments provide valuable insight into the types of projects and industries that have attracted their attention.

Startups and entrepreneurs operating in sectors related to Patient Care, Health Care, Regenerative Medicine, Genetics, Disruptive Innovation, Wellness, Fundraising, Investment Management, Healthcare Innovation, Life Science, Portfolio Management, Medical Technologies, Information Technology (IT), Due Diligence Services, Venture Fundraising, 3D Technology, Finance, Software, Intellectual Property, Manufacturing, Biotechnology, Medical Devices, Market Research, Electronic Health Records (EHR), Genomics, Health and Hospital Services, Precision Medicine, Communities, Clinical Trials, Technology Transfer, Digital Health, Regulatory Compliance, Renewable Energy, Medical, Information Technology, B2B, Therapeutics, Financial Advisory, Health Tech, Machine Learning, Emergency Medicine, Pharmaceuticals, Healthcare Technology, Risk Management may find it worthwhile to explore potential connections with Denis Lucquin, as their portfolio suggests a familiarity and interest in this area.

Understanding Denis Lucquin’s investment history can offer useful context for founders considering outreach and help identify whether there is a potential fit based on strategic alignment and market focus.